MPVlR、胱抑素(Cysc)与心肌易损期的相关研究

Correlation Studies between MPVLR, Cystatin (Cysc), and Myocardial Vulnerability Phase

心力衰竭是各种原因导致心脏结构和(或)功能改变,使心脏收缩和(或)舒张功能障碍,从而引起的一组复杂临床综合征。根据左心室射血分数(LVEF)将心力衰竭分为三类,其中将LVEF ≥ 50%的心力衰竭定义为HFpEF;此类患者通常合并症较多,基础功能较差,往往在住院治疗后的短期内容易再次入院或者发生卒中事件,因此为了降低HFpEF患者在心肌易损期内不良事件的发生率,根据心肌易损期的病理生理和临床特征,本文旨在研究mpvlr、CysC和心肌易损期的关系。

Heart failure is a group of complex clinical syndromes caused by various causes of structural and (or) functional changes, systolic and (or) diastolic dysfunction. According to the left ventricular ejection fraction (LVEF), heart failure is divided into three categories, in which 50% of LVEF is defined as HFpEF;such patients usually have more complications, poor basic function, and are often prone to re-admission or stroke events in the short term after hospitalization. Therefore, in order to reduce the incidence of adverse events in HFpEF patients during the myocardial vulnerability period, this paper aims to study the relationship between mpvlr, CysC and myocardial vulnerability period according to the pathophysiological and clinical characteristics of the myocardial vulnerability period.